Antimigratory effects of the methanol extract from momordica charantia on human lung adenocarcinoma CL1 cells

17Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Momordica charantia has been found to exhibit anticancer activity, in addition to its well-known therapeutic functions. We have demonstrated that the leaf extract of Momordica charantia (MCME) induces apoptosis in several human cancer cells through caspase- and mitochondria-dependent pathways. In this study, a different susceptibility to MCME was found in human lung adenocarcinoma CL1 cells with different metastatic ability, leading to the significant difference of cell viability and invasiveness between MCME-treated CL1-0 and CL1-5 cells. MCME was found to upregulate the expression of Wnt-2 and affect the migratory and invasive ability of CL1 cells through suppressed MMP-2 and MMP-9 enzymatic activities. We proposed that MCME mediates inhibition against migration of CL1 cells by reducing the expression and activation of Src and FAK to decrease the expression of downstream Akt, β-catenin, and MMPs. © 2012 Hsue-Yin Hsu et al.

Cite

CITATION STYLE

APA

Hsu, H. Y., Lin, J. H., Li, C. J., Tsang, S. F., Tsai, C. H., Chyuan, J. H., … Chuang, S. E. (2012). Antimigratory effects of the methanol extract from momordica charantia on human lung adenocarcinoma CL1 cells. Evidence-Based Complementary and Alternative Medicine, 2012. https://doi.org/10.1155/2012/819632

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free